Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis

R Kumar, A Kumar, R Patel, SS Prakash… - Indian Journal of …, 2024 - Springer
Background Antituberculosis drug-induced liver injury (ATDILI) is a significant problem of
tuberculosis treatment. This systematic review and meta‑analysis aimed at evaluating the …

Risk factors associated with post-tuberculosis sequelae: a systematic review and meta-analysis

TY Akalu, ACA Clements, AM Liyew, B Gilmour… - …, 2024 - thelancet.com
Background Post-tuberculosis (TB) sequelae present a significant challenge in the
management of TB survivors, often leading to persistent health issues even after successful …

Extra-abdominal involvement is associated with antitubercular therapy-related hepatitis in patients treated for abdominal tuberculosis

S Dawra, HS Mandavdhare, H Singh… - Clinical and …, 2019 - termedia.pl
Results Of 163 patients, 22 were excluded (17 missing information, 5 chronic liver disease).
One hundred and forty-one patients (mean age: 34.33±15.18 years, males: 72) were …

[PDF][PDF] Determine the hepatotoxicity with anti-tuberculosis drugs and its severity and frequency

UAQ UMAIR-UL-ISLAM, JA SAMO, I AHMED - Age (years), 2019 - pjmhsonline.com
Aim: To measure the frequency and severity of hepatotoxicity caused by various anti-
tuberculosis (ATT) drugs and assess whether concurrence of risk factors impact the …

[PDF][PDF] POLIMORFISMOS DE LOS GENES ENZIMÁTICOS NAT2, CYP2E1 Y GST Y PRESENCIA DE REACCIÓN ADVERSA A FÁRMACOS ANTITUBERCULOSOS EN …

LJJ VALVERDE - repositorio.upch.edu.pe
En el Perú, 24 581 personas fueron diagnosticadas con Tuberculosis (TB) en el 2020. Si
bien el tratamiento de la TB es efectivo, el 3.4-13% se asocia con reacciones adversas a …

[引用][C] Hepatotoxicidad por fármacos antituberculosos:¿ qué factores se ven implicados en su desarrollo?

MM Ferreiro Fernández, FS García Santana… - 2020 - Udelar. FM